imiquimod has been researched along with 3,4-dihydroxyphenyllactic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Jia, J; Li, H; Lin, Y; Liu, J; Mo, X; Wang, N; Yan, F; Zheng, Y | 1 |
1 other study(ies) available for imiquimod and 3,4-dihydroxyphenyllactic acid
| Article | Year |
|---|---|
Mechanism of danshensu-induced inhibition of abnormal epidermal proliferation in psoriasis.
Topics: Adaptor Proteins, Signal Transducing; Administration, Oral; Animals; Apoptosis; Cell Cycle Proteins; Cell Line; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Epidermis; Female; G1 Phase Cell Cycle Checkpoints; Humans; Imiquimod; Injections, Intraperitoneal; Keratinocytes; Lactates; Mice; Psoriasis; Salvia miltiorrhiza; Transcription Factors; YAP-Signaling Proteins | 2020 |